EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data

Krista M Schroeder iD, Ana Sofia Afonso, Huabo Wang, Sarah Grace, Adam Phipps, John R Sims

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-231488 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Krista M Schroeder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eli Lilly and Company, Indianapolis, IN, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Comorbidity, Medicare, Dementia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medicare claims data enables broad characterization of United States (US) patients with Alzheimer's disease and related dementias (ADRD). Resulting insights can be used as a reference to describe this population and as a benchmark for generalizability of patients with ADRD enrolled in clinical trials.

Objective

To characterize demographics, comorbidities, comedications, and healthcare resource utilization in US patients with newly diagnosed ADRD, focusing on differences across Medicare fee-for-service (FFS) and Medicare Advantage enrollees.

Methods

This observational cohort study used complete (100%) Medicare claims data inclusive of both FFS and Medicare Advantage insurance types. Study patients were ≥65-years-old with ≥12 months of continuous pre-index enrollment and Medicare Part D coverage. Two cohorts of patients were selected in calendar year 2019; those newly diagnosed with ADRD and those with a new acetylcholinesterase inhibitor (AChEI) claim.

Results

The newly diagnosed ADRD and new AChEI users cohorts included 861,727 and 395,319 patients, respectively. Demographics and comedications were generally similar across the two cohorts, supporting internal validity of the study results. Circulatory system-related comorbidities and mood disorders were common in both cohorts. Differences in race, inpatient claims and long-term care claims were observed between insurance types.

Conclusions

The study results provide a reference for describing the ADRD population in the US and emphasize the importance of evaluating new Alzheimer's disease drugs in broad patient populations with comorbidities and concomitant medication use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseComorbidityMedicareDementiaHumansUnited StatesMaleFemaleAgedAged, 80 and overCohort StudiesCholinesterase InhibitorsFee-for-Service PlansInsurance Claim Review

Stichwörter der Autor:innen

Alzheimer's disease and related dementiascholinesterase inhibitorsdementiamedicare

Substanzen

Cholinesterase Inhibitors

Autor:innen und Institutionen

  • Eli Lilly and Company, Indianapolis, IN, USA.
  • Eli Lilly Nederland BV, Utrecht, the Netherlands.
  • CareJourney, Arlington, VA, USA.

ORCID-Profile: Krista M Schroeder

Förderung

  • Eli Lilly and Company

Zitieren

APA

Schroeder, K. M., Afonso, A. S., Wang, H., Grace, S., Phipps, A., & Sims, J. R. (2024). Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-231488

Vancouver

Schroeder KM, Afonso AS, Wang H, Grace S, Phipps A, Sims JR. Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-231488

BibTeX
@article{Schroeder2024,
  author = {Schroeder, Krista M and Afonso, Ana Sofia and Wang, Huabo and Grace, Sarah and Phipps, Adam and Sims, John R},
  title = {Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-231488}
}
Kostenlos starten →